The country and pop music star Garth Brooks and his band members paid a special visit in July to the Child Life Zone at the Kravis Children’s Hospital at Mount Sinai to talk with pediatric patients and their families, play games, create artwork, and take photos. “The Zone,” which provides a fun and friendly environment for therapeutic and educational play activities, opened 10 years ago in partnership with the Garth Brooks Teammates for Kids Foundation and The Troy Aikman Foundation. Mr. Brooks and his band also appeared on a KidZone TV live broadcast, sharing stories and answering questions from pediatric patients in their hospital rooms. “The pure joy, energy, spirit, and warmth that Garth and the band brought to our children, teens, families, and staff was unparalleled,” says Diane Rode, Director, Child Life and Creative Arts Therapy Department, Kravis Children’s Hospital. “We are grateful every day for the power of ‘The Zone’ in helping us to humanize health care for our seriously ill children and their families.”
Neurosurgery patients at Mount Sinai Brooklyn can now receive in-depth evaluations, and local treatment in many cases, without having to travel into Manhattan. Ronit Gilad, MD, Chief of the Neurosurgical service at Mount Sinai Brooklyn, and Soriaya Motivala, MD, Co-Chief of the service, are leading the effort. Both are Assistant Professors of Neurosurgery at the Icahn School of Medicine at Mount Sinai and former Mount Sinai Neurosurgery residents. Read more
I want to provide a few updates regarding our progress on the Mount Sinai Downtown transformation. At the end of 2016 or the beginning of 2017, we will be relocating the MSBI cardiac surgery program to Mount Sinai St. Luke’s hospital.
This new comprehensive Center of Excellence will utilize our world-class surgical teams and increase our ability to continue delivering the high quality care that our patients have come to know and expect.
This change in no way means we will be eliminating cardiac care in our Downtown network. We will continue to treat patients at our 24-hour cardiac catheterization lab on our Petrie campus, and operate an emergency heart attack and stroke program at MSBI. These services will be transferred to our new Mount Sinai Beth Israel hospital on 14th Street when we complete construction.
Also, this week we went to market on the sale of Gilman Hall and surrounding buildings, all of which are vacant. All net proceeds from the sale will be invested back into the Mount Sinai Downtown network to enhance services and further our mission of transforming and enhancing care for Lower Manhattan residents.
Lastly, as you know, water samples in some areas of the hospital recently tested positive for Legionella bacteria. We have been working with the New York State Department of Health, and repeat testing of our water system has showed a marked reduction in the presence of Legionella. However, low levels still remain in some of the tested samples. As we continue to monitor our progress, filtered water restrictions will remain in place for the Dazian, Karpas, Linsky and Silver buildings to ensure the health and safety of our patients and staff.
We have had one patient who has hospital acquired Legionella pneumonia. The patient is being treated with appropriate antibiotics and her condition is improving. Legionella is not contagious and cannot be transmitted person to person. The hospital remains fully open and safe for patients and visitors.
Please continue to check back for more updates.
A recent reception and ribbon-cutting ceremony marked the opening of Mount Sinai Doctors East 85th Street, the first multispecialty Mount Sinai Doctors Faculty Practice on the Upper East Side. The office occupies five floors at 234 East 85th Street. Read more
For the third consecutive year, Annapoorna S. Kini, MD, Director of the Cardiac Catheterization Laboratory at The Mount Sinai Hospital, invited Mount Sinai Heart staff and their families to join her for a 5K run. More than 80 employees and their families participated in the event that took place on Saturday, May 21, in Central Park. “It is very important to practice what we preach,” says Dr. Kini (shown in photo at right, front row, center). “We tell our patients to exercise in order to be heart healthy. As staff, we need to serve as examples for our patients and make sure that we are heart healthy ourselves.” Dr. Kini, who is also Professor of Medicine (Cardiology), additionally encouraged staff from throughout the Hospital to participate in International Yoga Day on Tuesday, June 21 (left photo), a full-day event that attracted more than 100 individuals and featured meditation, yoga, and talks on nutrition.
Jan Christensen, a singer/songwriter and lymphoma survivor who was treated at Mount Sinai Beth Israel, entertained 200 guests at Mount Sinai’s 19th annual National Cancer Survivors Day® luncheon on Sunday, June 5, at Phillips Ambulatory Care Center. Among the attendees were cancer survivors, their families and friends, and Mount Sinai faculty and staff. Amy Porter-Tacoronte, MBA, Vice President of Oncology Services, Mount Sinai Health System, delivered the keynote address. Speakers included Herschey McGhee, a breast cancer survivor who was treated at Mount Sinai West; Daniel M. Labow, MD, Associate Professor, Surgery, Icahn School of Medicine at Mount Sinai, and Chief, Division of Surgical Oncology, The Mount Sinai Hospital; and Karen Lee, MSN, FNP-BC, Nurse Practitioner, Thoracic Oncology Program, Mount Sinai Beth Israel Comprehensive Cancer Center West.
A novel method for characterizing prostate cancer that uses computer vision and artificial intelligence to help determine the best course of treatment for each patient is being rolled out this summer by the Lillian and Henry M. Stratton-Hans Popper Department of Pathology at the Icahn School of Medicine at Mount Sinai.
The platform, called Precise Medical Diagnosis™ or Precise MD, has been under development at Mount Sinai for more than three years by a team of physicians, scientists, mathematicians, engineers, and programmers. The proprietary diagnostic system creates detailed, specific data about the patient’s cancer cells using multispectral fluorescent imaging to evaluate biomarker status and architectural patterns and then uses sophisticated computer analytics to combine and create predictive models. Read more
Researchers at the Icahn School of Medicine at Mount Sinai are pioneering the use of a new imaging agent used with positron emission tomography (PET) to detect and track the progression of repetitive traumatic brain injury in patients with a history of concussions.
The ability to actually see chronic traumatic encephalopathy (CTE) in living patients is particularly significant because the neurodegenerative disorder—associated with repetitive traumatic brain injury in athletes and soldiers—can only be definitively diagnosed in brain tissue after they are deceased. Read more
The Mount Sinai Hospital has been ranked No. 15 out of approximately 5,000 hospitals across the nation in the just-released 2016-2017 U.S. News & World Report “Best Hospitals” guidebook. Significantly, The Mount Sinai Hospital is one of only 20 hospitals nationwide to be named to the “Honor Roll,” which recognizes outstanding performance across multiple areas of care.
According to the rankings data, seven Mount Sinai Hospital departments ranked among the Top 20 nationally in their specialties, and four others were among the Top 50. The New York Eye and Ear Infirmary of Mount Sinai was also ranked nationally, No. 10 in Ophthalmology.
“We are extremely proud of our U.S. News rankings, especially this year, when Mount Sinai also excelled in the ‘Procedure and Condition Ratings,’ a separate, data-driven ranking of nine common procedures and conditions that formed an important component in Honor Roll calculations,” says Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System.
The Mount Sinai Hospital received Top 20 rankings in the following specialties:
- Geriatrics, No. 3
- Gastroenterology & GI Surgery, No. 7
- Cardiology & Heart Surgery, No. 8
- Diabetes & Endocrinology, No. 11
- Nephrology, No. 11
- Neurology & Neurosurgery, No. 12
- Ear, Nose & Throat, No. 20
Additionally, the following specialties received rankings:
- Urology, No. 29
- Cancer, No. 38
- Orthopaedics, No. 42
- Pulmonology, No. 45
Eight of the specialties improved their rankings from 2015-2016: Cancer; Diabetes & Endocrinology; Ear, Nose & Throat; Gastroenterology & GI Surgery; Nephrology; Neurology & Neurosurgery; Orthopaedics; and Pulmonology.
The Hospital was also recognized as “high performing” in Gynecology, Psychiatry, and Rehabilitation.
“These national rankings are the result of the exceptional care and unparalleled dedication to quality, safety, and service by The
Mount Sinai Hospital staff, and I remain confident that we will continue to receive high recognition in the years to come,” says David L. Reich, MD, President and Chief Operating Officer, The Mount Sinai Hospital.
Along with the New York Eye and Ear Infirmary of Mount Sinai, hospitals of the Mount Sinai Health System that received national recognition in the “Best Hospitals” rankings were:
- Mount Sinai Beth Israel, ranked as “high performing” in Neurology & Neurosurgery.
- Mount Sinai St. Luke’s/Mount Sinai West, ranked as “high performing” in Neurology & Neurosurgery, and Nephrology.
“Over the last few years, the Mount Sinai Health System has revolutionized delivery of care and scientific discovery, all to transform medicine and benefit our patients,” says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai and President for Academic Affairs, Mount Sinai Health System. “Excellence in the rankings is a reflection upon our outstanding School of Medicine faculty who staff our hospitals and who will continue to build on these achievements.”
Go to http://health.usnews.com/best-hospitals to view the 2016-2017 edition of “Best Hospitals.”
On September 25-28 2016, the Division of Occupation and Environmental Medicine at the Icahn School of Medicine at Mount Sinai will host MANGANESE2016, an international conference on the neurotoxicity and prevention of adverse manganese health effects.
Manganese is a metal used in the production of steel and other metal manufacturing. Industrial use of manganese sometimes releases high concentrations of it in the air via dust or fumes, making workers in these industries and residents of these areas especially susceptible to manganese-related health conditions. Read more